Pharma Tech

AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact

Oct 2, 2026, 1:30 PM

Read Full Article → AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact

Translate article text

Choose a language and wait for the translated text.

Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumours.